Tapewire

OTC · USD

EMMA

Emmaus Life Sciences, Inc.

Export transactions ↓
Tapewire entity
205
SEC CIK
0000822370
Parsed reports
310

Last 12 months

Inside the activity.

4 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202640
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 05, 2021 Filed Aug 5, 2021 21:39 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,600 $1.50 $2,400.00
Disclosure

SEC source: 0001209191-21-050028 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,818,071

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
August 04, 2021 Filed Aug 5, 2021 21:39 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 2,800 $1.48 $4,144.00
Disclosure

SEC source: 0001209191-21-050028 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,816,471

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.40 to $1.54, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
August 03, 2021 Filed Aug 5, 2021 21:39 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 3,200 $1.47 $4,704.00
Disclosure

SEC source: 0001209191-21-050028 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,813,671

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.41 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
August 02, 2021 Filed Aug 2, 2021 21:06 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 2,600 $1.47 $3,822.00
Disclosure

SEC source: 0001209191-21-049087 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,810,471

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2).

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 30, 2021 Filed Aug 2, 2021 21:06 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 500 $1.50 $750.00
Disclosure

SEC source: 0001209191-21-049087 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,807,871

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 29, 2021 Filed Aug 2, 2021 21:06 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,000 $1.50 $1,500.00
Disclosure

SEC source: 0001209191-21-049087 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,807,371

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 28, 2021 Filed Jul 28, 2021 20:34 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 2,400 $1.46 $3,504.00
Disclosure

SEC source: 0001209191-21-048431 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,806,371

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.45 to $1.49, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2).

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 27, 2021 Filed Jul 28, 2021 20:34 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 500 $1.50 $750.00
Disclosure

SEC source: 0001209191-21-048431 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,803,971

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 26, 2021 Filed Jul 28, 2021 20:34 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 500 $1.50 $750.00
Disclosure

SEC source: 0001209191-21-048431 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,803,471

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 23, 2021 Filed Jul 23, 2021 21:07 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,100 $1.49 $1,639.00
Disclosure

SEC source: 0001209191-21-047983 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,802,971

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.48 to $1.49, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 22, 2021 Filed Jul 23, 2021 21:07 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,000 $1.49 $1,490.00
Disclosure

SEC source: 0001209191-21-047983 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,801,871

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.48 to $1.49, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 21, 2021 Filed Jul 23, 2021 21:07 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 3,100 $1.46 $4,526.00
Disclosure

SEC source: 0001209191-21-047983 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,800,871

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.45 to $1.48, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 20, 2021 Filed Jul 20, 2021 21:24 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,800 $1.47 $2,646.00
Disclosure

SEC source: 0001209191-21-047437 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,797,771

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.43 to $1.48, inclusive.

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 19, 2021 Filed Jul 20, 2021 21:24 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 2,100 $1.46 $3,066.00
Disclosure

SEC source: 0001209191-21-047437 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,795,971

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.40 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnote (3) to this Form 4.

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 21:24 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,000 $1.50 $1,500.00
Disclosure

SEC source: 0001209191-21-047437 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,793,871

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 15, 2021 Filed Jul 15, 2021 21:47 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 2,200 $1.50 $3,300.00
Disclosure

SEC source: 0001209191-21-046807 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,792,871

F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.45 to $1.53, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 14, 2021 Filed Jul 15, 2021 21:47 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,300 $1.50 $1,950.00
Disclosure

SEC source: 0001209191-21-046807 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,790,671

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.48 to $1.50, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 13, 2021 Filed Jul 15, 2021 21:47 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,800 $1.52 $2,736.00
Disclosure

SEC source: 0001209191-21-046807 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,789,371

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.48 to $1.53, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3) and (4) to this Form 4.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 12, 2021 Filed Jul 12, 2021 23:37 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,000 $1.53 $1,530.00
Disclosure

SEC source: 0001209191-21-046365 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,787,571

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.53, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2).

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 09, 2021 Filed Jul 12, 2021 23:37 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,000 $1.54 $1,540.00
Disclosure

SEC source: 0001209191-21-046365 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,786,571

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 08, 2021 Filed Jul 12, 2021 23:37 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 2,000 $1.54 $3,080.00
Disclosure

SEC source: 0001209191-21-046365 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,785,571

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 07, 2021 Filed Jul 7, 2021 22:16 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,500 $1.54 $2,310.00
Disclosure

SEC source: 0001209191-21-045904 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,783,571

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 06, 2021 Filed Jul 7, 2021 22:16 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 800 $1.54 $1,232.00
Disclosure

SEC source: 0001209191-21-045904 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,782,071

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 02, 2021 Filed Jul 7, 2021 22:16 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,600 $1.51 $2,416.00
Disclosure

SEC source: 0001209191-21-045904 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,781,271

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.52, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
July 01, 2021 Filed Jul 1, 2021 22:10 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 500 $1.50 $750.00
Disclosure

SEC source: 0001209191-21-044549 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,779,671

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 30, 2021 Filed Jul 1, 2021 22:10 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 5,200 $1.42 $7,384.00
Disclosure

SEC source: 0001209191-21-044549 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,779,171

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.42, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 29, 2021 Filed Jul 1, 2021 22:10 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 4,300 $1.47 $6,321.00
Disclosure

SEC source: 0001209191-21-044549 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,773,971

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.45 to $1.47, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 28, 2021 Filed Jun 28, 2021 20:11 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 500 $1.49 $745.00
Disclosure

SEC source: 0001209191-21-043476 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,769,671

F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.48 to $1.50, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 25, 2021 Filed Jun 28, 2021 20:11 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 2,700 $1.48 $3,996.00
Disclosure

SEC source: 0001209191-21-043476 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,769,171

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.50, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 24, 2021 Filed Jun 28, 2021 20:11 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 600 $1.50 $900.00
Disclosure

SEC source: 0001209191-21-043476 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,766,471

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3) and (4) to this Form 4.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 22, 2021 Filed Jun 22, 2021 21:09 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 500 $1.59 $795.00
Disclosure

SEC source: 0001209191-21-042439 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,765,871

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 21, 2021 Filed Jun 22, 2021 21:09 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,250 $1.59 $1,987.50
Disclosure

SEC source: 0001209191-21-042439 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,765,371

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 18, 2021 Filed Jun 22, 2021 21:09 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 500 $1.59 $795.00
Disclosure

SEC source: 0001209191-21-042439 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,764,121

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 21:04 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 500 $1.60 $800.00
Disclosure

SEC source: 0001209191-21-041518 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,763,621

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 15, 2021 Filed Jun 17, 2021 21:04 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,990 $1.60 $3,184.00
Disclosure

SEC source: 0001209191-21-041518 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,763,121

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.60, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 14, 2021 Filed Jun 15, 2021 00:02 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,416 $1.60 $2,265.60
Disclosure

SEC source: 0001209191-21-040433 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,761,131

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.60, inclusive.

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 11, 2021 Filed Jun 15, 2021 00:02 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 800 $1.58 $1,264.00
Disclosure

SEC source: 0001209191-21-040433 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,759,715

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.55 to $1.59, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnote (3) to this Form 4.

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 10, 2021 Filed Jun 15, 2021 00:02 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,000 $1.65 $1,650.00
Disclosure

SEC source: 0001209191-21-040433 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,758,915

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 08, 2021 Filed Jun 9, 2021 22:19 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,000 $1.61 $1,610.00
Disclosure

SEC source: 0001209191-21-039260 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,757,915

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 07, 2021 Filed Jun 9, 2021 22:19 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 500 $1.55 $775.00
Disclosure

SEC source: 0001209191-21-039260 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,756,915

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 02, 2021 Filed Jun 3, 2021 23:25 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 465 $1.64 $762.60
Disclosure

SEC source: 0001209191-21-037935 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,756,415

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.65, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
June 01, 2021 Filed Jun 3, 2021 23:25 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,600 $1.61 $2,576.00
Disclosure

SEC source: 0001209191-21-037935 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,755,950

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.65, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
May 28, 2021 Filed May 28, 2021 22:09 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 12,900 $1.58 $20,382.00
Disclosure

SEC source: 0001209191-21-036633 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,754,350

F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.62, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
May 28, 2021 Filed May 28, 2021 22:02 UTC
LEE WILLIS CDirector · Vice Chairman & COO
PurchaseCommon stock, $0.001 par value 3,900 $1.57 $6,123.00
Disclosure

SEC source: 0001209191-21-036627 · doc4.xml · nonDerivative · entry 3

LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,674

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.61, inclusive.

Read SEC document
May 27, 2021 Filed May 28, 2021 22:09 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 2,300 $1.60 $3,680.00
Disclosure

SEC source: 0001209191-21-036633 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,741,450

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.61, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
May 27, 2021 Filed May 28, 2021 22:02 UTC
LEE WILLIS CDirector · Vice Chairman & COO
PurchaseCommon stock, $0.001 par value 2,000 $1.58 $3,160.00
Disclosure

SEC source: 0001209191-21-036627 · doc4.xml · nonDerivative · entry 2

LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,774

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.57 to $1.59, inclusive.

Read SEC document
May 26, 2021 Filed May 28, 2021 22:09 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 2,000 $1.54 $3,080.00
Disclosure

SEC source: 0001209191-21-036633 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,739,150

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.48 to $1.60, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3) and (4) to this Form 4.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
May 26, 2021 Filed May 28, 2021 22:02 UTC
LEE WILLIS CDirector · Vice Chairman & COO
PurchaseCommon stock, $0.001 par value 2,700 $1.53 $4,131.00
Disclosure

SEC source: 0001209191-21-036627 · doc4.xml · nonDerivative · entry 1

LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 244,774

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.51 to $1.59, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4.

Read SEC document
May 25, 2021 Filed May 25, 2021 23:50 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,500 $1.52 $2,280.00
Disclosure

SEC source: 0001209191-21-035813 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,737,150

F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.52 to $1.53, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
May 24, 2021 Filed May 25, 2021 23:50 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 1,000 $1.51 $1,510.00
Disclosure

SEC source: 0001209191-21-035813 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,735,650

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.53, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.